Corresponding Author Email: onosinandy@gmail.com

*ORCID: https://orcid.org/0000-0003-3690-5664

https://www.ajol.info/index.php/jasem

https://www.bioline.org.br/ja

J. Appl. Sci. Environ. Manage.

Vol. 29 (4) 1217-1227 April 2025

PRINT ISSN 1119-8362

Electronic ISSN 2659-1499

Sleep, Neuroendocrine Disorders, And the Bidirectional Relationship between the

Hypothalamic-Pituitary-Adrenal Axis: A Mini-Review

UDI, OA

Department of Human Anatomy, Faculty of Basic Medical Science, Federal University Otuoke, Bayelsa State, Nigeria

*Corresponding Author Email: onosinandy@gmail.com

*ORCID: https://orcid.org/0000-0003-3690-5664

*Tel: +2348037524881

ABSTRACT: This review explores the intricate and bidirectional relationships between the hypothalamic-

pituitary-adrenal (HPA) axis, sleep architecture and regulation, and the manifestation of various neuroendocrine disorders. The HPA axis, a critical component of the stress response system, exhibits diurnal rhythmicity and is

profoundly influenced by sleep. Conversely, HPA axis activity significantly impacts sleep quality, duration, and

consolidation. Disruptions in either the HPA axis or sleep can lead to or exacerbate a range of neuroendocrine disorders, including depression, anxiety disorders, Cushing's syndrome, Addison's disease, and sleep disorders

themselves (e.g., insomnia, sleep apnea). This review examines the physiological mechanisms underlying these

interactions, focusing on the roles of key hormones like cortisol, corticotropin-releasing hormone (CRH), and adrenocorticotropic hormone (ACTH). Furthermore, it discusses the clinical implications of these interrelationships,

including diagnostic considerations and potential therapeutic strategies that target the HPA axis and sleep pathways to

improve outcomes in individuals with neuroendocrine disorders. A thorough understanding of this complex interplay is crucial for developing effective interventions and personalized treatment approaches.

DOI: https://dx.doi.org/10.4314/jasem.v29i4.25

License: CC-BY-4.0

Open Access Policy: All articles published by JASEM are open-access and free for anyone to download, copy,

redistribute, repost, translate and read.

Copyright Policy: © 2025. Authors retain the copyright and grant JASEM the right of first publication. Any

part of the article may be reused without permission, provided that the original article is cited.

Cite this Article as: UDI, O. A (2025). Sleep, Neuroendocrine Disorders, And the Bidirectional Relationship

between the Hypothalamic-Pituitary-Adrenal (Hpa) Axis: A Mini-Review. J. Appl. Sci. Environ. Manage. 29

(4) 1217-1227

Dates: Received: 27 February 2025; Revised: 26 March 2025; Accepted: 10 April 2025; Published: 30 April

2025

Keywords: Sleep Apnea; Cushing's syndrome; Addison's disease; Stress Response; Hypothalamic-Pituitary-

Adrenal

The human body has an intricate system for

responding to stress and maintaining homeostasis,

known as the Hypothalamic-Pituitary-Adrenal (HPA)

axis (Mbiydzenyuy and Qulu, 2024). The HPA axis

is a complex network of interactions between the

hypothalamus, pituitary gland, and adrenal glands,

which work together to release hormones in response

to stress (Mueller et al., 2022; Esegbue et al., 2019).

When the body experiences stress, the hypothalamus

releases corticotropin-releasing hormone (CRH),

which then triggers the pituitary gland to release

adrenocorticotropic hormone (ACTH). ACTH then

signals the adrenal glands to produce cortisol, the

primary stress hormone, which helps the body

respond to stress by increasing energy, alertness, and

immune function. Once the stressor is removed, the

levels of CRH, ACTH, and cortisol decrease, and the

body returns to a state of homeostasis (Hinds and

Sanchez, 2022; Milleniari, 2023). Sleep architecture

is another critical aspect of human health, consisting

of distinct stages that cycle throughout the night.

These stages include wakefulness, rapid eye

movement (REM) sleep, and non-REM sleep, which

is further divided into three stages. Each stage serves

a particular function in the restorative process of

sleep, with non-REM sleep being essential for

physical recovery and REM sleep playing a crucial

role in cognitive functions such as memory

Sleep, Neuroendocrine Disorders, And the Bidirectional Relationship between the Hypothalamic… 1218

UDI, O. A

consolidation. The importance of sleep for overall

health cannot be overstated, as it affects various

aspects, including memory, mood, immune function,

and cardiovascular health (Chokroverty, 2017;

Baranwal et al., 2022). Neuroendocrine disorders

refer to conditions that affect the complex

interactions between the nervous and endocrine

systems. These disorders can result in hormonal

imbalances, which can have significant impacts on

various bodily functions, including growth,

metabolism, and stress response. Neuroendocrine

disorders can arise from genetic or environmental

factors, with some being more prevalent than others.

Common examples of neuroendocrine disorders

include diabetes, acromegaly, and Cushing's disease,

all of which can have profound effects on an

individual's overall health and quality of life (Bala et

al., 2021; Kivimäki et al., 2023).

Significance of Interplay: The hypothalamic-

pituitary-adrenal (HPA) axis, sleep, and

neuroendocrine function are intricately intertwined in

a complex, bidirectional relationship. The HPA axis,

as the body's primary stress response system,

influences both sleep architecture and the release of

various hormones, including cortisol (Dressle et al.,

2022). Conversely, sleep disturbances, whether

chronic insomnia or shift work-related disruptions,

can significantly impact HPA axis activity, often

leading to elevated cortisol levels. Furthermore,

neuroendocrine hormones, such as growth hormone

and melatonin, which are regulated by both the HPA

axis and sleep, play a vital role in modulating sleep

cycles and HPA axis responsivity (Smith and Mong,

2019). This complex dance highlights a system where

dysfunction in one area can cascade and disrupt the

others. Grasping this complex interaction is essential

for deciphering the underlying mechanisms of

various disorders and formulating effective treatment

approaches. For example, chronic stress and

disrupted sleep, often leading to HPA axis

dysregulation, are implicated in conditions ranging

from depression and anxiety to metabolic syndrome

and autoimmune diseases. By recognizing the

bidirectional influences between these systems,

clinicians can adopt a more holistic approach,

targeting multiple aspects of the system for more

effective interventions. Treating insomnia, managing

stress levels, and optimizing neuroendocrine function

could all contribute to improving HPA axis

regulation and ultimately alleviating symptoms of

associated disorders. A comprehensive understanding

at the systems level offers insights for creating

focused therapies that recognize and tackle the

complex nature of these interrelated systems, giving

hope for innovative and more efficient treatments.

MATERIALS AND METHOD The search strategy involved leveraging the PubMed

and Web of Science databases. Studies were selected

if they explored the connection between sleep

patterns and HPA axis function in individuals,

regardless of whether they had diagnosed

neuroendocrine disorders. The exclusion criteria

included studies that focused exclusively on

pharmacological treatments without analyzing the

underlying neuroendocrine mechanisms, animal

studies, and articles published in languages other than

English. The chosen articles were subsequently

evaluated for their methodological soundness, sample

size, and the clarity of their results, emphasizing the

examination of bidirectional connections between

sleep architecture and HPA axis activity within

different neuroendocrine disorders. The insights

obtained from these studies were then integrated to

offer a succinct overview of the existing knowledge

regarding this intricate relationship. The primary

objective is to analyze existing literature to address

key questions regarding how these neuroendocrine

imbalances affect: (1) sleep latency and efficiency,

(2) the duration and proportion of different sleep

stages, (3) the presence and severity of sleep-

disordered breathing, and (4) the overall subjective

sleep quality reported by affected individuals.

The Hypothalamic-Pituitary-Adrenal (HPA) Axis:

The hypothalamus, a small but vital region located

deep within the brain, serves as the control center for

the HPA axis (Udi, 2025; Heck and Handa, 2019).

Think of it as the conductor of an orchestra,

orchestrating the hormonal responses to a diverse

array of inputs. It constantly monitors internal and

external cues, including stress signals (like

encountering a dangerous situation or experiencing

emotional distress), inflammatory responses (like

fighting off an infection), and circadian signals

(related to the daily light-dark cycle). When the

hypothalamus detects a stressor or receives specific

circadian signals, it initiates the HPA axis cascade.

This cascade begins with the release of corticotropin-

releasing hormone (CRH), a neuropeptide that acts as

the primary messenger within the HPA axis. CRH is

secreted from the hypothalamus and travels a short

distance to the anterior pituitary gland, a pea-sized

gland situated just below the hypothalamus. Upon

reaching the anterior pituitary, CRH binds to specific

receptors, stimulating the synthesis and release

of adrenocorticotropic hormone (ACTH). ACTH is a

peptide hormone that enters the bloodstream and

embarks on a journey to its target organ: the adrenal

cortex. The adrenal glands are two small, triangular-

shaped glands located on top of the kidneys (Paloka

et al., 2022). Each adrenal gland has two distinct

Sleep, Neuroendocrine Disorders, And the Bidirectional Relationship between the Hypothalamic… 1219

UDI, O. A

regions: the inner medulla (responsible for adrenaline

production) and the outer cortex. It is the adrenal

cortex that receives the ACTH signal. When ACTH

reaches the adrenal cortex, it binds to receptors on the

cells of the cortex, triggering a complex enzymatic

process that leads to the synthesis and release

of cortisol. Cortisol, often referred to as the "stress

hormone," is a glucocorticoid hormone with

widespread effects throughout the body. It plays a

crucial role in regulating glucose metabolism,

suppressing the immune system, assisting in fat,

protein and carbohydrate metabolism, and increasing

alertness. Its release is essential for mobilizing

energy reserves to cope with stress, manage blood

sugar levels, and modulate the immune response. For

example, during a stressful situation like public

speaking, cortisol helps provide the energy needed to

perform and focuses attention on the task at hand

(Das et al., 2024; Goel et al., 2023; Heck and Handa,

2019; Vashishth et al., 2024).

The synthesis of cortisol within the adrenal cortex is

a meticulous and multi-stepped process. It begins

with cholesterol as the precursor molecule.

Cholesterol is converted into cortisol through a series

of enzymatic reactions, each catalyzed by a specific

enzyme. These enzymes are located within the

mitochondria and endoplasmic reticulum of the

adrenal cortex cells. Because cholesterol is the

initiating element in this process, sufficient

availability of it is essential for the body to manage

stress well. To prevent excessive cortisol production

and maintain hormonal equilibrium, the HPA axis

operates under a tightly controlled negative feedback

mechanism (Androulakis 2021). As cortisol levels

rise in the bloodstream, they act as inhibitors,

signaling back to both the hypothalamus and the

pituitary gland. High cortisol levels suppress the

release of CRH from the hypothalamus, reducing the

drive for ACTH production. Simultaneously, cortisol

inhibits the pituitary gland's responsiveness to CRH,

further dampening ACTH release (Al-Suhaimi et al.,

2022). This negative feedback loop ensures that

cortisol levels do not spiral out of control, preventing

potential damage to the body. This intricate control

mechanism is akin to a thermostat, maintaining

cortisol levels within a healthy range. Beyond its role

in stress response, the HPA axis is also deeply

intertwined with the circadian rhythm. The circadian

rhythm is an internal biological clock that regulates

numerous physiological processes, including the

sleep-wake cycle, hormone secretion, body

temperature, and metabolism, over a roughly 24-hour

period. The suprachiasmatic nucleus (SCN) in the

hypothalamus is considered the master pacemaker of

the circadian clock. The SCN receives light

information from the retina and synchronizes the

body's internal rhythms with the external

environment. Cortisol secretion exhibits a distinct

circadian pattern. Typically, cortisol levels are

highest in the morning, peaking shortly after waking.

This morning surge in cortisol promotes alertness,

enhances cognitive function, and prepares the body

for the demands of the day. As the day progresses,

cortisol levels gradually decline, reaching their

lowest point around midnight, promoting relaxation

and facilitating sleep. This circadian regulation of

cortisol ensures that the body's stress response system

is primed for the predictable challenges of daily

activities (Agorastos, 2020; Luo, et al., 2021).

Disruption of the circadian rhythm through factors

such as shift work, frequent travel across time zones

(jet lag), irregular sleep schedules, or exposure to

artificial light at night can severely impact HPA axis

function. Such disruptions can lead to alterations in

cortisol secretion patterns, potentially resulting in

chronically elevated cortisol levels, impaired stress

response, metabolic dysregulation, sleep

disturbances, mood disorders, and a weakened

immune system. For example, individuals working

night shifts often experience chronic stress, sleep

problems, and increased risk of metabolic diseases

due to the misalignment of their circadian rhythm and

their work schedule (Cingi et al., 2018; Steinach and

Gunga, 2020).

HPA Axis and Stress Response: The hypothalamic-

pituitary-adrenal (HPA) axis is a crucial

neuroendocrine system that orchestrates the body's

response to stress, both acute and chronic (Kinlein

and Karatsoreos, 2020). When faced with a stressor,

the hypothalamus releases corticotropin-releasing

hormone (CRH), which triggers the pituitary gland to

release adrenocorticotropic hormone (ACTH). ACTH

then travels through the bloodstream to the adrenal

glands, stimulating them to produce cortisol, the

primary stress hormone. This cortisol surge mobilizes

energy reserves by increasing glucose levels,

suppressing non-essential functions like digestion,

and enhancing cardiovascular tone to prepare the

body for "fight or flight." This acute response is

adaptive, enabling us to effectively deal with

immediate threats. However, prolonged activation of

the HPA axis in response to chronic stressors can

have detrimental consequences on various

physiological systems. Constant exposure to elevated

cortisol levels can suppress the immune system,

making individuals more susceptible to infections

and autoimmune disorders. Metabolically, chronic

stress can lead to insulin resistance, weight gain, and

an increased risk of type 2 diabetes and

Sleep, Neuroendocrine Disorders, And the Bidirectional Relationship between the Hypothalamic… 1220

UDI, O. A

cardiovascular disease (Al-Suhaimi, et al., 2022).

Furthermore, prolonged HPA axis activation can

significantly impact the brain, leading to neuronal

damage in areas like the hippocampus (crucial for

memory) and contributing to anxiety, depression, and

cognitive impairments (Sharan and Vellapandian,

2024). The delicate balance of the HPA axis is thus

essential for maintaining health, and chronic

disruption can pave the way for a cascade of negative

health outcomes.

HPA Axis Dysfunction: Dysfunction within the HPA

axis can manifest in various ways, with significant

consequences for overall health, including profound

effects on sleep. Cushing's syndrome, characterized

by hypercortisolism (excess cortisol), can stem from

various causes, such as pituitary tumors or prolonged

use of corticosteroid medications. Its symptoms

include weight gain, particularly in the trunk and

face, high blood pressure, muscle weakness, and

cognitive impairments (Reincke and Fleseriu, 2023).

Insomnia, fragmented sleep, and decreased slow-

wave sleep are frequently caused by the high cortisol

levels in Cushing's syndrome, which also interfere

with the regular sleep-wake cycle (Dressle et al.,

2022). On the other hand, injury to the adrenal glands

causes Addison's disease, which is caused by

hypocortisolism (insufficient cortisol). Fatigue,

weakness in the muscles, weight loss, low blood

pressure, and darkening of the skin are some of the

symptoms. Due to the absence of cortisol, Addison's

disease patients may have severe daytime drowsiness,

trouble falling and staying asleep, and even the

possibility of developing sleep apnea. Other illnesses

including chronic stress and trauma can also cause

disruption of the HPA axis, in addition to these

particular disorders. Chronic HPA axis activation

brought on by extended stress can contribute to

anxiety, sadness, and disturbed sleep patterns, which

are frequently characterized by trouble falling asleep

and frequent awakenings (Kalmbach et al., 2018).

Similarly, HPA axis reactivity can be permanently

changed by trauma, especially early-life trauma,

increasing the likelihood of stress-related diseases

and sleep difficulties in later life (Blake et al., 2018).

For people with HPA axis dysfunction, creating

focused interventions to enhance sleep quality and

general well-being requires an understanding of the

complex link between the HPA axis and sleep.

Sleep Architecture and Regulation

Stages of Sleep: Sleep is not a monolithic state, but

rather a cyclical journey through distinct stages, each

characterized by unique physiological and

neurological changes. These stages can be broadly

categorized into Non-Rapid Eye Movement (NREM)

sleep and Rapid Eye Movement (REM) sleep. The

three stages of NREM sleep are NREM 1, NREM 2,

and NREM 3. Theta waves predominate during

NREM 1, the slower brainwave activity that occurs

during the transition between awake and sleep.

Muscles relax, and breathing and heart rate start to

decrease. NREM 2 is a deeper sleep stage where

theta waves continue, interspersed with sleep spindles

and K-complexes, which protect the brain from being

aroused by external stimuli. Heart rate and body

temperature further decrease. Lastly, the largest and

slowest brainwaves, known as delta waves, are what

define NREM 3, sometimes referred to as deep sleep

or slow-wave sleep. The immune system, muscle

growth, and physical healing all depend on this stage,

which is also the most difficult to awaken. Brain

activity is greatly decreased, and breathing and heart

rate are at their slowest (Andrillon, 2023; Avidan

2022; Satapathy et al., 2021; Prerau et al., 2017).

After progressing through NREM sleep, the cycle

shifts into REM sleep. In stark contrast to the slow,

synchronized brain activity of NREM 3, REM sleep

is characterized by rapid, desynchronized brainwave

activity resembling wakefulness. Rapid eye

movements take place under closed eyelids, as the

term implies. Blood pressure rises as breathing and

heart rate become erratic and rapid. Ironically, the

muscles are effectively paralyzed, preventing the

body from enacting dreams, even while the brain is

very active. Emotional processing, memory

consolidation, and vivid dreams are all closely linked

to this stage. The whole sleep cycle, from NREM 1 to

REM, usually lasts between 90 and 120 minutes. It is

repeated multiple times during the night, and the

amount of time spent in each stage changes as the

night goes on (Koob and Colrain, 2020; Prerau et al.,

2017).

Regulation of Sleep-Wake Cycle: An intricate web of

internal and external variables carefully controls the

sleep-wake cycle, a basic biological function. The

hypothalamic small cluster of neurons known as the

suprachiasmatic nucleus (SCN) is at the center of this

regulation. Sleep is regulated by circadian rhythms,

which are about 24-hour cycles produced by the

SCN, which serves as the body's master clock (Pandi-

Perumal et al., 2022). These rhythms are entrained,

or synchronized, to the outside world, mostly via

light exposure that is recognized by the eyes, rather

than being fixed. Hormones and neurotransmitters are

also important in regulating wakefulness and sleep

patterns. The pineal gland produces the hormone

melatonin, which is sometimes called the "sleep

hormone" because it increases in the evening and

encourages drowsiness (Samanta, 2022). Adenosine,

Sleep, Neuroendocrine Disorders, And the Bidirectional Relationship between the Hypothalamic… 1221

UDI, O. A

a neurotransmitter that accumulates throughout the

day as a byproduct of cellular activity, also

contributes to sleep pressure, making us feel tired and

eventually leading to sleep. The interplay between

these and other neurochemicals fine-tunes our sleep-

wake cycle to ensure we are aware and effective

during the day and restful during the night.

Ultimately, the control of the sleep-wake cycle is

greatly influenced by outside variables. An important

synchronizer that suppresses melatonin production

and promotes wakefulness is light exposure, as was

previously indicated. Likewise, temperature has an

impact on sleep; in general, a cooler setting promotes

the onset and maintenance of sleep. Exercise,

mealtimes, and social interactions are a few other

outside factors that can have an indirect impact on the

SCN and help regulate the sleep-wake cycle overall.

Unbalances in the circadian rhythm and sleep

disorders can arise from disruptions to these external

cues, such as shift work or jet lag (Foster, 2020).

Sleep Disorders: Stress, poor sleep hygiene, or

underlying medical conditions are often the triggers

for insomnia, which is characterized by difficulty

falling or staying asleep and can be classified into

acute and chronic forms. Sleep disorders are a serious

public health concern that include a variety of

conditions that interfere with normal sleep patterns.

Long-term sleeplessness can cause the hypothalamic-

pituitary-adrenal (HPA) axis to become dysregulated,

which raises cortisol levels and intensifies the stress

response. Obstructive and central apnea is two types

of sleep apnea, a disorder characterized by breathing

pauses during sleep (Chokroverty, 2017).

The intermittent hypoxia associated with sleep apnea

can activate the HPA axis, contributing to increased

blood pressure and cardiovascular risk. Narcolepsy, a

neurological disorder characterized by excessive

daytime sleepiness and cataplexy, is thought to be

caused by a deficiency in hypocretin, a

neurotransmitter that also influences hormonal

regulation. Sufferers experience hormonal changes

linked to sleep irregularities. Restless legs syndrome

(RLS), characterized by an irresistible urge to move

the legs, particularly at night, can significantly

disrupt sleep and lead to distress, some studies have

suggested a relationship between the systems.

Finally, Parasomnias, such as sleepwalking and night

terrors, involve abnormal behaviors during sleep and

may arise from disruptions in neuroendocrine

function, although the precise mechanisms are still

unclear (Mansukhani, 2017; Wilson et al., 2018;

Wang et al., 2021).

Neuroendocrine Disorders

Specific Disorders and Their Hormonal Imbalances:

Thyroid disorders, both hyperthyroidism and

hypothyroidism, can significantly disrupt sleep

patterns and influence the hypothalamic-pituitary-

adrenal (HPA) axis, a key regulator of the stress

response. Hyperthyroidism, characterized by an

overactive thyroid gland, often leads to insomnia,

difficulty falling asleep, and frequent awakenings due

to increased metabolic activity and anxiety

(Yiallouris et al., 2024). This state of heightened

arousal can also chronically activate the HPA axis,

potentially leading to elevated cortisol levels, which

further exacerbate sleep disturbances and may

contribute to long-term health consequences.

Conversely, hypothyroidism, caused by an

underactive thyroid gland, can manifest as excessive

daytime sleepiness and increased sleep duration.

While individuals might sleep longer, the quality of

sleep is often poor, with complaints of feeling

unrefreshed. Though the processes are less

understood than in hyperthyroidism, hypothyroidism

can also indirectly impact the HPA axis and result in

changes to the generation and control of cortisol.

Thus, maintaining a balanced HPA axis and

reestablishing good sleep patterns depend on properly

controlling thyroid function. The hypothalamic-

pituitary-adrenal (HPA) axis, a critical modulator of

stress response and circadian rhythms, and sleep

architecture can be profoundly affected by growth

hormone (GH) problems (Knezevic et al., 2023).

Sleep habits are frequently disturbed by acromegaly,

which is defined by high growth hormone production

in adults. Reduced slow-wave sleep (SWS) and rapid

eye movement (REM) sleep are among the changes

in sleep stages that have been documented in studies.

These changes may result in daytime weariness and

cognitive impairment (Lafrenière et al., 2023; Wood

et al., 2021; Diep et al., 2020). Moreover,

acromegaly may contribute to elevated cortisol

secretion and exacerbate sleep difficulties by

dysregulating the HPA axis. On the other hand, GH

insufficiency, whether in childhood or maturity, can

similarly affect HPA axis activity and sleep. Sleep

architecture changes, such as decreased SWS and

increased fragmentation, have been associated with

GH insufficiency. It has a complicated effect on the

HPA axis; some research indicates disruption of the

diurnal cortisol rhythm, while others imply lower

cortisol levels and a compromised stress response

(Wood et al., 2021; Diep et al., 2020). It is essential

to comprehend the complex interactions among sleep,

GH problems, and HPA axis function in order to

design tailored treatments that will enhance patient

outcomes.

Sleep, Neuroendocrine Disorders, And the Bidirectional Relationship between the Hypothalamic… 1222

UDI, O. A

Sleep and the hypothalamic-pituitary-adrenal (HPA)

axis, a crucial component for the stress response, are

both greatly impacted by reproductive hormone

abnormalities. Women with PCOS, a condition

marked by hormonal imbalances, frequently

experience disturbed sleep patterns and changed HPA

axis activity, which may exacerbate anxiety and

metabolic problems. Similarly, insomnia and hot

flashes are often linked to menopause, which is

characterized by a decrease in estrogen and

progesterone. These symptoms both affect the quality

of sleep and activate the HPA axis (Hantsoo et al.,

2023). Last but not least, hypogonadism, which

affects both men and women and involves a decrease

in the synthesis of sex hormones, can also change

hormone-mediated signaling pathways that affect

sleep regulation and disturb sleep patterns.

Developing focused therapies to enhance sleep and

general health in people with these reproductive

hormonal disorders requires an understanding of

these connections.

Sleep and the hypothalamic-pituitary-adrenal (HPA)

axis can be severely disrupted by a range of less

frequent but no less serious illnesses, which extend

beyond the well-known adrenal disorders of

Cushing's syndrome and Addison's disease. The

genetic condition known as congenital adrenal

hyperplasia (CAH), which affects the adrenal glands'

capacity to produce cortisol, might result in excessive

androgen production. This can then impact the

architecture of sleep, perhaps causing disruptions

(Hughes et al., 2019). The HPA axis may be directly

impacted by the changed hormonal milieu in CAH,

which is caused by both excess androgens and

insufficient cortisol. This can result in dysregulation

and interfere with the regular diurnal cortisol rhythm,

which is essential for sleep-wake cycles.

Similarly, sleep can be severely disrupted by

pheochromocytoma, a rare tumor of the adrenal

medulla that results in an excess of catecholamines

such as noradrenaline and adrenaline. These "fight-

or-flight" hormones can cause anxiety, insomnia, and

night sweats, which can disrupt sleep and make it

difficult to have periods of rest.

Furthermore, the chronic overstimulation caused by

pheochromocytoma can profoundly influence the

HPA axis, potentially causing significant alterations

in cortisol levels and influencing the body's stress

response system, further exacerbating sleep

disturbances. Understanding the particular processes

by which these adrenal diseases affect sleep and the

HPA axis is critical for designing tailored therapeutic

approaches to enhance patient outcomes.

The Role of Hormones in Sleep Regulation:

Hormones play a critical role in regulating sleep,

acting as key messengers that orchestrate the

complex processes involved in sleep initiation,

maintenance, and architecture. Melatonin, often

dubbed the "sleep hormone," is central to this

process. Released by the pineal gland in response to

darkness, melatonin promotes sleepiness and helps to

regulate the sleep-wake cycle, facilitating both the

onset and maintenance of sleep. The stress hormone

cortisol, on the other hand, has a clear circadian

rhythm; it usually peaks in the morning to encourage

alertness and progressively decreases throughout the

day to aid in the onset of sleep. The sleep-wake cycle

can be greatly impacted by disturbances in the

cortisol rhythm, which can lead to insomnia and other

sleep problems. Thyroid hormones can have a

significant impact on the structure and general quality

of sleep. Both hyperthyroidism and hypothyroidism

can interfere with sleep cycles, resulting in

diminished slow-wave sleep, trouble falling asleep,

and frequent awakenings. In addition to these major

actors, other hormones that regulate hunger, such as

ghrelin and leptin, also affect sleep. The complex

relationship between hormonal regulation and the

sleep-wake cycle is highlighted by the fact that

imbalances in these hormones can impact the length

and quality of sleep. (Camberos-Barraza et al., 2024).

The Interplay: HPA Axis, Sleep, and Neuroendocrine

Disorders

Bidirectional Relationships: The bidirectional

interaction between sleep and the hypothalamic-

pituitary-adrenal (HPA) axis is complex, meaning

that each can have a significant impact on the other.

Insomnia and other sleep problems can be further

exacerbated by dysfunction in the HPA axis, which is

typified by persistent activation or suppression. For

example, disturbed sleep start and maintenance can

result in fragmented and non-restorative sleep due to

increased cortisol levels, which are a sign of chronic

stress and hyperactivity of the HPA axis. On the

other hand, sleep disorders themselves can have a

devastating effect on the activity of the HPA axis.

Over time, chronic sleep deprivation or irregular

sleep patterns may contribute to HPA axis

hyperactivity by dysregulating cortisol secretion,

which can result in increased levels in the evening

when they should be decreasing. Additionally, sleep

architecture and HPA axis function are frequently

disrupted by neuroendocrine disorders like Addison's

disease (cortisol deficiency) and Cushing's syndrome

(excess cortisol). This leads to a vicious cycle in

which hormone imbalances worsen sleep issues,

which in turn causes poor sleep to further disrupt

hormonal regulation. Given the interdependence of

Sleep, Neuroendocrine Disorders, And the Bidirectional Relationship between the Hypothalamic… 1223

UDI, O. A

these systems, this complex interaction emphasizes

the necessity of a comprehensive strategy for treating

sleep issues or HPA axis dysfunction (Mueller et al.,

2022; Hinds and Sanchez, 2022).

Mechanisms of Interaction: The intricate interplay

between neurological and systemic processes hinges

on several key mechanisms. Neurotransmitter

pathways, such as those utilizing GABA, glutamate,

and serotonin, serve as critical communication

networks. Disruptions in these pathways, whether

through imbalances in neurotransmitter release,

receptor sensitivity, or reuptake mechanisms, can

have profound effects far beyond localized brain

function. Furthermore, inflammatory processes play a

significant role in this interaction. Chronic or

dysregulated inflammation, both within the brain

(neuroinflammation) and systemically, can alter

neurotransmitter function and contribute to

neurodegeneration, impacting cognitive and

behavioral outcomes. Finally, genetic factors

introduce an element of predisposition, influencing

individual vulnerability to these interactions.

Variations in genes related to neurotransmitter

synthesis, inflammatory pathways, and immune

function can collectively determine the susceptibility

to neurological disorders influenced by systemic

processes and vice versa (Konstantinou et al., 2022;

Firdaus and Li, 2024). Understanding these

multifaceted mechanisms is crucial for developing

targeted therapeutic interventions.

Clinical Manifestations: When several illnesses

coexist in one patient, the clinical signs of endocrine

disorders can become quite complicated. For

instance, sleeplessness may also be present in a

patient with Cushing's syndrome, which is defined by

extended exposure to elevated cortisol levels. The

excess cortisol can disrupt the normal sleep-wake

cycle, exacerbating pre-existing sleep difficulties or

even inducing new ones (Dressle et al., 2022).

Managing these patients poses significant challenges,

as attributing specific symptoms to a single

underlying cause becomes difficult. The complex

interplay between conditions like Cushing's

syndrome and insomnia necessitates a holistic

approach to diagnosis and treatment. Clinicians must

carefully differentiate between the symptoms

stemming from each condition and consider the

potential impact of one on the other. This often

requires a combination of biochemical testing,

imaging studies, and thorough patient history,

followed by a tailored treatment plan that addresses

both the root causes and the symptomatic burden of

each condition.

Therapeutic and Diagnostic Methods

Diagnostic Tools: Diagnostic instruments are

essential for assessing a range of medical disorders,

especially those involving sleep and hormone

abnormalities. The quality of sleep is evaluated using

a variety of techniques, such as actigraphy,

polysomnography, and sleep diaries. By recording

heart rate, breathing, oxygen levels, and brain waves,

polysomnography is a thorough examination that

offers extensive insights into the structure and

disruptions of sleep. Actigraphy, on the other hand,

involves wearing a wrist device that tracks

movement, thus offering a more accessible way to

gauge sleep patterns over an extended period. Sleep

diaries, kept by individuals over time, serve as a

subjective tool to document sleep habits, contributing

valuable qualitative data to the assessment process. In

addition to sleep assessments, hormonal testing is

critical for identifying endocrine disruptions. Cortisol

level tests, such as the ACTH stimulation test, assess

how well the adrenal glands are working and can

assist diagnose diseases like Addison's disease or

Cushing's syndrome. Thyroid hormones are essential

for controlling metabolism and energy expenditure,

and thyroid function tests measure their levels in the

body. These hormone tests can provide a clearer

picture of an individual's health status, directing

treatment procedures and lifestyle improvements

(Hussain et al., 2022; Baker et al., 2018).

Additionally, imaging methods are crucial to the

diagnosis procedure, especially when looking at

hormone issues. By seeing the pituitary and adrenal

glands via magnetic resonance imaging (MRI),

medical professionals can spot any abnormalities or

possible malignancies that might be affecting

hormone production. Clinicians can create more

focused and efficient interventions by integrating the

findings of imaging examinations, hormonal testing,

and sleep evaluations to gain a thorough picture of a

patient's health.

Therapeutic Interventions: Addressing the

multifaceted challenges of perimenopause requires a

comprehensive approach that often incorporates both

pharmacological and non-pharmacological

therapeutic interventions. Pharmacological treatments

frequently involve Hormone Replacement Therapy

(HRT) to alleviate hormonal imbalances and

associated symptoms like hot flashes and mood

changes. Furthermore, medications targeting sleep

disorders, such as hypnotics for short-term relief or

antidepressants, which can improve sleep quality and

address underlying mood disturbances, may be

prescribed (Palagini et al., 2024). In some cases,

medications to modulate the Hypothalamic-Pituitary-

Adrenal (HPA) axis, the body's stress response

Sleep, Neuroendocrine Disorders, And the Bidirectional Relationship between the Hypothalamic… 1224

UDI, O. A

system, might be considered to regulate cortisol

levels and reduce anxiety. Complementing these

pharmacological options are non-pharmacological

interventions, including Cognitive Behavioral

Therapy for Insomnia (CBT-I), a structured program

to improve sleep habits and address negative thoughts

surrounding sleep (Kristiansen et al., 2024). Light

therapy can be beneficial for regulating circadian

rhythms and improving mood, particularly during the

darker months. Moreover, stress management

techniques, such as mindfulness and meditation,

coupled with lifestyle modifications like dietary

adjustments and regular exercise, play a crucial role

in managing symptoms and promoting overall well-

being during this transitional phase.

Personalized Medicine: A paradigm change in

healthcare is represented by personalized medicine,

which moves away from a "one-size-fits-all"

approach to therapy and toward methods that are

specifically customized for each patient. This novel

method makes use of a patient's distinct traits,

including their lifestyle, genetic composition, and

coexisting medical disorders (comorbidities), to

identify the best preventative, diagnostic, and

treatment measures. In order to maximize therapy

results, reduce side effects, and ultimately enhance

patient well-being, customized medicine seeks to

understand the unique biological and environmental

elements driving disease in each individual. In

addition to avoiding treatments that are unlikely to be

beneficial or may even be harmful, this enables

doctors to make well-informed decisions regarding

which drugs or therapies are most likely to be

successful for a certain patient (Kristiansen et al.,

2024; Andrew et al., 2017).

Future Directions and Research Gaps: For future

studies to completely clarify the intricate interactions

between the conditions under investigation, a number

of important open questions must be addressed. More

precisely, there are still many unanswered questions

regarding the exact mechanisms underlying the

relationships that have been discovered, necessitating

the investigation of numerous biological pathways

and environmental factors. Finding possible

therapeutic targets is another important direction for

further research, with an emphasis on cutting-edge

therapies that might alter particular neurotransmitter

receptors or reduce inflammatory pathways linked to

these interactions. Last but not least, longitudinal

research is essential. To appropriately evaluate the

long-term effects of these interactions and to

ascertain how well putative therapies work to

mitigate adverse outcomes, it is imperative to track

patient cohorts over longer periods of time. Such

long-term information will be crucial for creating

thorough and individualized treatment plans.

Conclusion: To sum up, this review has brought to

light the complex interactions among the

neuroendocrine system, sleep regulation, and the

hypothalamic-pituitary-adrenal (HPA) axis. The main

conclusions point to a complicated reciprocal

interaction in which disturbances in one area might

have a substantial effect on the others, resulting in a

series of physiological and psychological

repercussions. Taking these results into account, a

number of clinical practice implications become

apparent. In order to diagnose and treat patients who

may have a combination of sleep, neuroendocrine,

and HPA axis issues, this study suggests using a

more thorough and integrated approach. This entails

meticulous evaluation of neuroendocrine aspects that

may be influencing the clinical picture, as well as

comprehensive screening for sleep difficulties in

patients with established HPA axis dysfunction and

vice versa. Lastly, it is critical to stress the

significance of a patient-centered approach. In

addition to treating specific symptoms, effective care

must take into account the complex relationships

between these systems, lifestyle choices, stress levels,

and mental health in order to maximize patient

outcomes and enhance quality of life in general.

Declaration of Conflict of Interest: There is no

conflict of interest.

Data Availability: Data are available upon request

from the corresponding author.

REFERENCES Agorastos, A; Nicolaides, NC; Bozikas, VP;

Chrousos, GP; Pervanidou, P (2020). Multilevel

interactions of stress and circadian system:

implications for traumatic stress. Front.

Psych. 10:1003.

Al-Suhaimi, EA; Aljfary, MA; Aldossary, H;

Alshammari, T; AL-Qaaneh, A; Aldahhan, R;

Alkhalifah, Z (2022). Mechanism of hormones

secretion and action. Emerg. Conc. Endo. Struct.

Fun. 2:47-71.

Andrew, UO; Ozoko, LEC; Kingsley, IA; Mamerhi,

ET; Beauty, E (2017). Histologic effect of garlic

extract on the spleen of adult wistar rat. J Pharm

Biol Sci, 12:1-4.

Andrillon, T (2023). How we sleep: from brain states

to processes. Rev. Neuro. 179(7): 649-657.

Sleep, Neuroendocrine Disorders, And the Bidirectional Relationship between the Hypothalamic… 1225

UDI, O. A

Androulakis, IP (2021). Circadian rhythms and the

HPA axis: A systems view. WIREs mech.

Dis. 13(4): e1518.

Avidan, AY (2022). Normal sleep in humans. Atlas

of Clinical Sleep Medicine. Else. Heal. Sci. 3: 83-

116.

Bala, R; Singh, V; Rajender, S; Singh, K (2021).

Environment, lifestyle, and female

infertility. Repro. Sci. 28(3):617-638.

Baker, FC; De Zambotti, M; Colrain, IM.; Bei, B

(2018). Sleep problems during the menopausal

transition: prevalence, impact, and management

challenges. Nat. Sci. Sle. p. 73-95.

Baranwal, N; Phoebe, KY; Siegel, NS (2023). Sleep

physiology, pathophysiology, and sleep

hygiene. Prog. Cardio. Dis. 77:59-69.

Blake, MJ; Trinder, JA; Allen, NB (2018).

Mechanisms underlying the association between

insomnia, anxiety, and depression in adolescence:

implications for behavioral sleep

interventions. Clinical psych. Rev. 63:25-40.

Camberos-Barraza, J; Camacho-Zamora, A; Bátiz-

Beltrán, JC; Osuna-Ramos, JF; Rábago-Monzón,

ÁR; Valdez-Flores, MA; De la Herrán-Arita, AK

(2024). Sleep, glial function, and the

endocannabinoid system: implications for

neuroinflammation and sleep disorders. Interna. J.

Mol. Sci. 25(6):3160.

Chokroverty, S (2017). Overview of normal

sleep. Sleep disorders medicine: Bas. Sci. Tech.

Consid. Clin. Asp. 5-27.

Cingi, C; Emre, IE; Muluk, NB (2018). Jetlag related

sleep problems and their management: A

review. Tra. Med. Infect. Dis. 24:59-64.

Das, A; Suar, M; Reddy, KS (2024). Hormones in

malaria infection: influence on disease severity,

host physiology, and therapeutic

opportunities. Bio. Rep. 44(11):202.

Dressle, RJ; Feige, B; Spiegelhalder, K; Schmucker,

C; Benz, F; Mey, NC; Riemann, D (2022). HPA

axis activity in patients with chronic insomnia: a

systematic review and meta-analysis of case–

control studies. Sl. Med. Rev. 62:101588.

Diep, C; Ftouni, S; Manousakis, JE; Nicholas, CL;

Drummond, SP; Anderson, C (2020). Acoustic

slow wave sleep enhancement via a novel,

automated device improves executive function in

middle-aged men. Sle. 43(1): zsz197.

Esegbue, PRC; Uyovwiesevwa, AJ; Olowe, GT; Udi,

OA (2019). Reversibility, Body Weight and

Histo-architectural Alterations in the Anterior

Pituitary Gland of Aqueous Azadirachta indica

Extract Fed Wistar Rats. Asia. J. Adv. Res.

Rep. 6(4):1-7.

Firdaus, Z; Li, X (2024). Unraveling the genetic

landscape of neurological disorders: insights into

pathogenesis, techniques for variant identification,

and therapeutic approaches. Intern. J. Mol.

Sci. 25(4):2320.

Foster, RG (2020). Sleep, circadian rhythms and

health. Inter. Foc. 10(3):20190098.

Goel, M; Mittal, A; Jain, VR; Bharadwaj, A; Modi,

S; Ahuja, G; Kumar, K (2023). Integrative

Functions of the Hypothalamus: Linking

Cognition, Emotion and Physiology for Well-

being and Adaptability. An. Neur.

Hantsoo, L; Jagodnik, KM; Novick, AM; Baweja, R;

di Scalea, TL; Ozerdem, A; Weiss, SJ (2023). The

role of the hypothalamic-pituitary-adrenal axis in

depression across the female reproductive

lifecycle: current knowledge and future

directions. Front. Endocri. 14:1295261.

Heck, AL; Handa, RJ (2019). Sex differences in the

hypothalamic–pituitary–adrenal axis’ response to

stress: an important role for gonadal

hormones. Neuropsych. 44(1):45-58.

Hinds, JA; Sanchez, ER (2022). The role of the

hypothalamus–pituitary–adrenal (HPA) axis in

test-induced anxiety: assessments, physiological

responses, and molecular details. Stres. 2(1):146-

155.

Hughes, CR; Man, E; Achermann, JC (2019). The

adrenal cortex and its disorders. Bro. Cli. Pedia.

Endocri. p. 335-407.

Hussain, S; Mubeen, I; Ullah, N; Shah, SSUD; Khan,

BA; Zahoor, M; Sultan, MA (2022). Modern

diagnostic imaging technique applications and

risk factors in the medical field: a review. Bio.

Res. Intern. 2022(1):5164970.

Kalmbach, DA; Anderson, JR; Drake, CL (2018).

The impact of stress on sleep: pathogenic sleep

Sleep, Neuroendocrine Disorders, And the Bidirectional Relationship between the Hypothalamic… 1226

UDI, O. A

reactivity as a vulnerability to insomnia and

circadian disorders. J. Sle. Res. 27(6):e12710.

Kivimäki, M; Bartolomucci, A; Kawachi, I (2023).

The multiple roles of life stress in metabolic

disorders. Nat. Rev. Endocri. 19(1):10-27.

Kinlein, SA; Karatsoreos, IN (2020). The

hypothalamic-pituitary-adrenal axis as a substrate

for stress resilience: Interactions with the

circadian clock. Front Neuroendo. 56:100819.

Koob, GF; Colrain, IM (2020). Alcohol use disorder

and sleep disturbances: a feed-forward allostatic

framework. Neuropsy. 45(1):141-165.

Knezevic, E; Nenic, K; Milanovic, V; Knezevic, NN

(2023). The role of cortisol in chronic stress,

neurodegenerative diseases, and psychological

disorders. Cells. 12(23):2726.

Konstantinou, GN; Konstantinou, GN; Koulias, C;

Petalas, K; Makris, M (2022). Further

understanding of neuro-immune interactions in

allergy: implications in pathophysiology and role

in disease progression. J. Asth. Aller. p.1273-

1291.

Kristiansen, ST; Lyhne, CN; Kragh, M; Sigaard, KR;

Videbech, P; Larsen, ER; Bjerrum, MB (2024).

Experiences of adult patients living with

depression-related insomnia: a qualitative

systematic review. JBI Evi. Syn. 22(12):2447-

2517.

Lafrenière, A; Lina, JM; Hernandez, J; Bouchard, M;

Gosselin, N; Carrier, J (2023). Sleep slow waves’

negative-to-positive-phase transition: a marker of

cognitive and apneic status in

aging. Sle. 46(1):zsac246.

Luo, S; Ezrokhi, M; Cominos, N; Tsai, TH; Stoelzel,

CR; Trubitsyna, Y; Cincotta, AH (2021).

Experimental dopaminergic neuron lesion at the

area of the biological clock pacemaker,

suprachiasmatic nuclei (SCN) induces metabolic

syndrome in rats. Diab. Met. Synd. 13:1-17.

Mansukhani, MP; Covassin, N; Somers, VK (2019).

Apneic sleep, insufficient sleep, and

hypertension. Hyper. 73(4):744-756.

Mbiydzenyuy, NE; Qulu, LA (2024). Stress,

hypothalamic-pituitary-adrenal axis,

hypothalamic-pituitary-gonadal axis, and

aggression. Metabo. Bra. Dis, 1-24.

Milleniari, RFDI (2023). Neuroendocrine: the

Hypothalamus-Pituitary-Adrenal axis and the

relation to stroke. Gan. Med. 3(1):6-13.

Mueller, B; Figueroa, A; Robinson-Papp, J (2022).

Structural and functional connections between the

autonomic nervous system, hypothalamic–

pituitary–adrenal axis, and the immune system: a

context and time dependent stress response

network. Neuro. Sci. 43(2):951-960.

Palagini, L; Miniati, M; Marazziti, D; Riemann, D;

Geoffroy, PA; Gemignani, A (2024). Effects of

approved pharmacological interventions for

insomnia on mood disorders: a systematic

review. Cli. Neuro. 21(5):385.

Paloka, R; Gopireddy, DR; Virarkar, M; Galgano, SJ;

Morani, A; Adimula, P; Montanarella, M (2022).

Multimodality imaging of adrenal gland

pathologies: A comprehensive pictorial review. J.

Clin. Imag. Sci. 12:62.

Pandi-Perumal, SR; Cardinali, DP; Zaki, NF;

Karthikeyan, R; Spence, DW; Reiter, RJ; Brown,

GM (2022). Timing is everything: Circadian

rhythms and their role in the control of

sleep. Fron. Neuroendo. 66:100978.

Prerau, MJ; Brown, RE; Bianchi, MT; Ellenbogen,

JM; Purdon, PL (2017). Sleep neurophysiological

dynamics through the lens of multitaper spectral

analysis. Physio. 32(1): 60-92.

Reincke, M; Fleseriu, M (2023). Cushing syndrome:

a review. Jama. 330(2):170-181.

Samanta, S (2022). Physiological and

pharmacological perspectives of melatonin. Arch.

Physio. Bioch. 128(5):1346-1367.

Satapathy, SK; Bhoi, AK; Loganathan, D (2021). A

review on psychological brainwaves behavior

during sleep: causes and diagnosis. Bio-insp.

Neuro. p.105-130.

Sharan, P; Vellapandian, C (2024). Hypothalamic-

Pituitary-Adrenal (HPA) Axis: Unveiling the

Potential Mechanisms Involved in Stress-Induced

Alzheimer’s Disease and

Depression. Cureus, 16(8).

Steinach, M; Gunga, HC (2020). Circadian rhythm

and stress. Stress Challenges and Immunity in

Space: From Mechanisms to Monitoring and

Preventive Strategies. 145-179.

Sleep, Neuroendocrine Disorders, And the Bidirectional Relationship between the Hypothalamic… 1227

UDI, O. A

Smith, PC; Mong, JA. (2019). Neuroendocrine

control of sleep. Neuroend. Reg. Beh. 5:353-378.

Udi, OA (2025). Bidirectional Communication

Network: Exploring the Gut-Brain Axis as a target

for Ocimum gratissimum modulation in

Neurodegenerative Disorder. J. Appl. Sci.

Environ. Manage. 29 (2): 407-416

Vashishth, S; Ambasta, RK; Kumar, P (2024).

Deciphering the Microbial Map and its

implications in the therapeutics of

Neurodegenerative Disorder. Ag. Res. Rev.

102466.

Yiallouris, A; Filippou, C; Themistocleous, SC;

Menelaou, K; Kalodimou, V; Michaeloudes, C;

Johnson, EO (2024). Aging of the adrenal gland

and its impact on the stress response. Vit.

Horm. 124:341-366.

Wang, W; Zheng, Y; Li, M; Lin, S; Lin, H (2021).

Recent advances in studies on the role of

neuroendocrine disorders in obstructive sleep

apnea–hypopnea syndrome-related

atherosclerosis. Nat. Sci. Sle. p.1331-1345.

Wilson, EN; Anderson, M; Snyder, B; Duong, P;

Trieu, J; Schreihofer, DA; Cunningham, RL

(2018). Chronic intermittent hypoxia induces

hormonal and male sexual behavioral changes:

hypoxia as an advancer of aging. Physio.

Beha. 189:64-73.

Wood, KH; Memon, AA; Memon, RA; Joop, A;

Pilkington, J; Catiul, C; Amara, AW (2021). Slow

wave sleep and EEG delta spectral power are

associated with cognitive function in Parkinson’s

disease. J. Parki. Dis. 11(2):703-714.